pyridine has been researched along with 1,4,7-triazacyclononane-n,n',n''-triacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlin, SD; Lewis, JS; Mohindra, P; Reiner, T; Sevak, KK; Weissleder, R; Zanzonico, P; Zeglis, BM | 1 |
| Ait-Mohand, S; Guérin, B; Khosravifarsani, M; Paquette, B; Sanche, L | 1 |
2 other study(ies) available for pyridine and 1,4,7-triazacyclononane-n,n',n''-triacetic acid
| Article | Year |
|---|---|
A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
Topics: Animals; Antibodies; Cell Line, Tumor; Click Chemistry; Copper Radioisotopes; Cyclooctanes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals | 2013 |
High Cytotoxic Effect by Combining Copper-64 with a NOTA-Terpyridine Platinum Conjugate.
Topics: Antineoplastic Agents; Cell Line; Cell Nucleus; Cell Survival; Coordination Complexes; Copper Radioisotopes; Drug Screening Assays, Antitumor; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Kinetics; Platinum; Pyridines; Radiopharmaceuticals | 2021 |